321 related articles for article (PubMed ID: 11695559)
21. Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity.
Park CB; Kim DJ; Uehara N; Takasuka N; Hiroyasu BT; Tsuda H
Cancer Lett; 1999 May; 139(2):177-82. PubMed ID: 10395176
[TBL] [Abstract][Full Text] [Related]
22. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis.
Tamaoki N
Toxicol Pathol; 2001; 29 Suppl():81-9. PubMed ID: 11695564
[TBL] [Abstract][Full Text] [Related]
23. Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment.
Gulezian D; Jacobson-Kram D; McCullough CB; Olson H; Recio L; Robinson D; Storer R; Tennant R; Ward JM; Neumann DA
Toxicol Pathol; 2000; 28(3):482-99. PubMed ID: 10862569
[TBL] [Abstract][Full Text] [Related]
24. Carcinogenic responses of transgenic heterozygous p53 knockout mice to inhaled 239PuO2 or metallic beryllium.
Finch GL; March TH; Hahn FF; Barr EB; Belinsky SA; Hoover MD; Lechner JF; Nikula KJ; Hobbs CH
Toxicol Pathol; 1998; 26(4):484-91. PubMed ID: 9715507
[TBL] [Abstract][Full Text] [Related]
25. Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice.
Salim EI; Wanibuchi H; Morimura K; Wei M; Mitsuhashi M; Yoshida K; Endo G; Fukushima S
Carcinogenesis; 2003 Feb; 24(2):335-42. PubMed ID: 12584185
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous and chemically induced proliferative lesions in Tg.AC transgenic and p53-heterozygous mice.
Mahler JF; Flagler ND; Malarkey DE; Mann PC; Haseman JK; Eastin W
Toxicol Pathol; 1998; 26(4):501-11. PubMed ID: 9715509
[TBL] [Abstract][Full Text] [Related]
27. The Trp53 hemizygous mouse in pharmaceutical development: points to consider for pathologists.
Floyd E; Mann P; Long G; Ochoa R
Toxicol Pathol; 2002; 30(1):147-56. PubMed ID: 11890468
[TBL] [Abstract][Full Text] [Related]
28. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice.
Dunnick JK; Hardisty JF; Herbert RA; Seely JC; Furedi-Machacek EM; Foley JF; Lacks GD; Stasiewicz S; French JE
Toxicol Pathol; 1997; 25(6):533-40. PubMed ID: 9437796
[TBL] [Abstract][Full Text] [Related]
29. Genotoxicity and carcinogenicity studies of soy isoflavones.
Misra RR; Hursting SD; Perkins SN; Sathyamoorthy N; Mirsalis JC; Riccio ES; Crowell JA
Int J Toxicol; 2002; 21(4):277-85. PubMed ID: 12171629
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.
Couto SS; Cao M; Duarte PC; Banach-Petrosky W; Wang S; Romanienko P; Wu H; Cardiff RD; Abate-Shen C; Cunha GR
Differentiation; 2009 Jan; 77(1):103-11. PubMed ID: 19281769
[TBL] [Abstract][Full Text] [Related]
31. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
32. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
33. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
34. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services
Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420
[TBL] [Abstract][Full Text] [Related]
35. Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthalein.
Hulla JE; French JE; Dunnick JK
Toxicol Sci; 2001 Apr; 60(2):264-70. PubMed ID: 11248138
[TBL] [Abstract][Full Text] [Related]
36. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
[TBL] [Abstract][Full Text] [Related]
37. Use of p53 transgenic mice in the development of cancer models for multiple purposes.
Lubet RA; Zhang Z; Wiseman RW; You M
Exp Lung Res; 2000 Dec; 26(8):581-93. PubMed ID: 11195457
[TBL] [Abstract][Full Text] [Related]
38. [The mutagenic and carcinogenic activity of chemical compounds].
Rakitskiĭ VN; Turusov VS
Vestn Ross Akad Med Nauk; 2005; (3):7-9. PubMed ID: 15852703
[TBL] [Abstract][Full Text] [Related]
39. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.
Venkatachalam S; Shi YP; Jones SN; Vogel H; Bradley A; Pinkel D; Donehower LA
EMBO J; 1998 Aug; 17(16):4657-67. PubMed ID: 9707425
[TBL] [Abstract][Full Text] [Related]
40. Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood.
Ranaldi R; Palma S; Tanzarella C; Lascialfari A; Cinelli S; Pacchierotti F
Mutat Res; 2007 Feb; 615(1-2):57-65. PubMed ID: 17109898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
